Literature DB >> 6301442

Human plasma alpha 1- and alpha 2-thiol proteinase inhibitors strongly inhibit Ca-activated neutral protease from muscle.

M Sasaki, K Taniguchi, K Suzuki, K Imahori.   

Abstract

Human plasma alpha 1- and alpha 2-thiol proteinase inhibitors (alpha 1,2TPIs) inhibited purified Ca-activated neutral protease (CANP) most strongly among a number of thiol proteinases tested. When CANP was added to plasma, it was also inhibited by alpha 2-macroglobulin (alpha 2M). At low CANP concentrations, CANP was bound mainly to alpha 1,2TPIs; and after saturation of alpha 1,2TPIs the additional CANP was bound to alpha 2M. These data suggested that a probable role of alpha 1,2TPIs is to neutralize the proteolytic activity of the CANP derived from the tissues in collaboration with alpha 2M.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6301442     DOI: 10.1016/0006-291x(83)91288-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Inhibition of chicken calpain II by proteins of the cystatin superfamily and alpha 2-macroglobulin.

Authors:  C Crawford
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

2.  Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases.

Authors:  G Salvesen; C Parkes; M Abrahamson; A Grubb; A J Barrett
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

Review 3.  Cysteine proteinases and metastasis.

Authors:  B F Sloane; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

4.  Human plasma alpha-cysteine proteinase inhibitor. Purification by affinity chromatography, characterization and isolation of an active fragment.

Authors:  A D Gounaris; M A Brown; A J Barrett
Journal:  Biochem J       Date:  1984-07-15       Impact factor: 3.857

Review 5.  Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors.

Authors:  Marton Siklos; Manel BenAissa; Gregory R J Thatcher
Journal:  Acta Pharm Sin B       Date:  2015-09-26       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.